Identification of a novel HASPIN inhibitor and its synergism with the PLK1 inhibitor
E.-J. Kwon, K. Mashelkar, J. Seo, Y. Shin, K. Sung, S. C. Jang, S. W. Cheon, H. Lee, B. W. Han, L. S. Jeong, H.-J. Cha
The paper identifies a novel HASPIN inhibitor, LJ4827, and shows its synergistic effect with PLK1 inhibitor BI2536 in lung cancer treatment.
bioRxiv · Sep 1, 2022 · PreprintPharmacology & Toxicology